Cargando…
A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma
Chordoma is a rare malignant bone tumor that mainly occurs in the sacrum and the clivus/skull base. Surgical resection is the treatment of choice for chordoma, but the local recurrence rate is high with unsatisfactory prognosis. Compared with other common tumors, there is not much research and indiv...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708744/ https://www.ncbi.nlm.nih.gov/pubmed/36465398 http://dx.doi.org/10.3389/fonc.2022.1029670 |
_version_ | 1784841005183270912 |
---|---|
author | Zhao, Chenglong Tan, Tao Zhang, E. Wang, Ting Gong, Haiyi Jia, Qi Liu, Tielong Yang, Xinghai Zhao, Jian Wu, Zhipeng Wei, Haifeng Xiao, Jianru Yang, Cheng |
author_facet | Zhao, Chenglong Tan, Tao Zhang, E. Wang, Ting Gong, Haiyi Jia, Qi Liu, Tielong Yang, Xinghai Zhao, Jian Wu, Zhipeng Wei, Haifeng Xiao, Jianru Yang, Cheng |
author_sort | Zhao, Chenglong |
collection | PubMed |
description | Chordoma is a rare malignant bone tumor that mainly occurs in the sacrum and the clivus/skull base. Surgical resection is the treatment of choice for chordoma, but the local recurrence rate is high with unsatisfactory prognosis. Compared with other common tumors, there is not much research and individualized treatment for chordoma, partly due to the rarity of the disease and the lack of appropriate disease models, which delay the discovery of therapeutic strategies. Recent advances in modern techniques have enabled gaining a better understanding of a number of rare diseases, including chordoma. Since the beginning of the 21st century, various chordoma cell lines and animal models have been reported, which have partially revealed the intrinsic mechanisms of tumor initiation and progression with the use of next-generation sequencing (NGS) techniques. In this study, we performed a systematic overview of the chordoma models and related sequencing studies in a chronological manner, from the first patient-derived chordoma cell line (U-CH1) to diverse preclinical models such as the patient-derived organoid-based xenograft (PDX) and patient-derived organoid (PDO) models. The use of modern sequencing techniques has discovered mutations and expression signatures that are considered potential treatment targets, such as the expression of Brachyury and overactivated receptor tyrosine kinases (RTKs). Moreover, computational and bioinformatics techniques have made drug repositioning/repurposing and individualized high-throughput drug screening available. These advantages facilitate the research and development of comprehensive and personalized treatment strategies for indicated patients and will dramatically improve their prognoses in the near feature. |
format | Online Article Text |
id | pubmed-9708744 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-97087442022-12-01 A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma Zhao, Chenglong Tan, Tao Zhang, E. Wang, Ting Gong, Haiyi Jia, Qi Liu, Tielong Yang, Xinghai Zhao, Jian Wu, Zhipeng Wei, Haifeng Xiao, Jianru Yang, Cheng Front Oncol Oncology Chordoma is a rare malignant bone tumor that mainly occurs in the sacrum and the clivus/skull base. Surgical resection is the treatment of choice for chordoma, but the local recurrence rate is high with unsatisfactory prognosis. Compared with other common tumors, there is not much research and individualized treatment for chordoma, partly due to the rarity of the disease and the lack of appropriate disease models, which delay the discovery of therapeutic strategies. Recent advances in modern techniques have enabled gaining a better understanding of a number of rare diseases, including chordoma. Since the beginning of the 21st century, various chordoma cell lines and animal models have been reported, which have partially revealed the intrinsic mechanisms of tumor initiation and progression with the use of next-generation sequencing (NGS) techniques. In this study, we performed a systematic overview of the chordoma models and related sequencing studies in a chronological manner, from the first patient-derived chordoma cell line (U-CH1) to diverse preclinical models such as the patient-derived organoid-based xenograft (PDX) and patient-derived organoid (PDO) models. The use of modern sequencing techniques has discovered mutations and expression signatures that are considered potential treatment targets, such as the expression of Brachyury and overactivated receptor tyrosine kinases (RTKs). Moreover, computational and bioinformatics techniques have made drug repositioning/repurposing and individualized high-throughput drug screening available. These advantages facilitate the research and development of comprehensive and personalized treatment strategies for indicated patients and will dramatically improve their prognoses in the near feature. Frontiers Media S.A. 2022-11-16 /pmc/articles/PMC9708744/ /pubmed/36465398 http://dx.doi.org/10.3389/fonc.2022.1029670 Text en Copyright © 2022 Zhao, Tan, Zhang, Wang, Gong, Jia, Liu, Yang, Zhao, Wu, Wei, Xiao and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Zhao, Chenglong Tan, Tao Zhang, E. Wang, Ting Gong, Haiyi Jia, Qi Liu, Tielong Yang, Xinghai Zhao, Jian Wu, Zhipeng Wei, Haifeng Xiao, Jianru Yang, Cheng A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
title | A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
title_full | A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
title_fullStr | A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
title_full_unstemmed | A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
title_short | A chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
title_sort | chronicle review of new techniques that facilitate the understanding and development of optimal individualized therapeutic strategies for chordoma |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708744/ https://www.ncbi.nlm.nih.gov/pubmed/36465398 http://dx.doi.org/10.3389/fonc.2022.1029670 |
work_keys_str_mv | AT zhaochenglong achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT tantao achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT zhange achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT wangting achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT gonghaiyi achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT jiaqi achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT liutielong achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT yangxinghai achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT zhaojian achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT wuzhipeng achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT weihaifeng achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT xiaojianru achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT yangcheng achroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT zhaochenglong chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT tantao chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT zhange chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT wangting chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT gonghaiyi chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT jiaqi chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT liutielong chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT yangxinghai chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT zhaojian chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT wuzhipeng chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT weihaifeng chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT xiaojianru chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma AT yangcheng chroniclereviewofnewtechniquesthatfacilitatetheunderstandinganddevelopmentofoptimalindividualizedtherapeuticstrategiesforchordoma |